dehydroepiandrosterone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Good, AC; Peterson, SJ; Richards, WG | 1 |
Callier, S; D'Astous, M; Di Paolo, T; Morissette, M; Tanguay, B | 1 |
Bédard, P; Bélanger, N; Di Paolo, T; Grégoire, L | 1 |
Bédard, PJ; Bélanger, N; Di Paolo, T; Grégoire, L | 1 |
4 other study(ies) available for dehydroepiandrosterone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
Topics: Carbolines; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Imidazoles; Indoles; Molecular Structure; Pyridines; Structure-Activity Relationship | 1993 |
Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dehydroepiandrosterone; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Estradiol; Homovanillic Acid; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dehydroepiandrosterone; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Female; Functional Laterality; Levodopa; Macaca fascicularis; Motor Activity; Ovariectomy; Parkinson Disease, Secondary | 2003 |
DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dehydroepiandrosterone; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinsonian Disorders; Severity of Illness Index | 2006 |